US Patent 11866502 Anti-FGFR2 antibodies and methods of use thereof
Patent 11866502 was granted and assigned to Regeneron Pharmaceuticals on January, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11866502 Anti-FGFR2 antibodies and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.